Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin de Bock

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
BMJ Open|February 21, 2024
Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trialTom Wilkinson, Dunya Tomic, Erin Boyle, et al.
Frontiers in Endocrinology|November 30, 2023
Following in Banting's footsteps or straying from the path? Observations from contemporary diabetes innovationConnor Leadley, Ananta Addala, Juliet Berkeley, et al.
Diabetes Technology & Therapeutics|June 4, 2021
A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is MaintainedThomas Danne, Stefanie Lanzinger, Martin de Bock, et al.
Diabetes Technology & Therapeutics|January 27, 2025
EValuating Glucose ContrOL Using a Next-GeneraTION Automated Insulin Delivery Algorithm in Patients with Type 1 and Type 2 Diabetes: The EVOLUTION StudyTom Wilkinson, Renee Meier, Niranjala Hewapathirana, et al.
Journal of Diabetes and Metabolic Disorders|December 13, 2021
A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocolSara Styles, Ben Wheeler, Alisa Boucsein, et al.
JAMA Network Open|August 27, 2025
Global Inequities in Diabetes Technology and Insulin Access and Glycemic OutcomesAlzbeta Santova, Martin de Bock, Stefanie Lanzinger, et al.
Diabetologia|October 23, 2023
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data InfrastructureNicholas Bowden, Rachael Dixon, Vivienne Anderson, et al.
Hormone Research in Paediatrics|December 19, 2024
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic TargetsMartin de Bock, Juliana Chizo Agwu, Matt Deabreu, et al.
JMIR Diabetes|May 28, 2026
Exploring User Experiences With the Lift App for Emotional Well-Being Among Youth With Type 1 Diabetes: Qualitative StudyKatie M Babbott, Kristin Harrison Ginsberg, Anna L Boggiss, et al.
BMC Endocrine Disorders|August 30, 2024
Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: a single-arm multi-phase intervention studyShekhar Sehgal, Martin De Bock, Benyamin Grosman, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
BMJ Open|February 21, 2024
Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trialTom Wilkinson, Dunya Tomic, Erin Boyle, et al.
Frontiers in Endocrinology|November 30, 2023
Following in Banting's footsteps or straying from the path? Observations from contemporary diabetes innovationConnor Leadley, Ananta Addala, Juliet Berkeley, et al.
Diabetes Technology & Therapeutics|June 4, 2021
A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is MaintainedThomas Danne, Stefanie Lanzinger, Martin de Bock, et al.
Diabetes Technology & Therapeutics|January 27, 2025
EValuating Glucose ContrOL Using a Next-GeneraTION Automated Insulin Delivery Algorithm in Patients with Type 1 and Type 2 Diabetes: The EVOLUTION StudyTom Wilkinson, Renee Meier, Niranjala Hewapathirana, et al.
Journal of Diabetes and Metabolic Disorders|December 13, 2021
A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocolSara Styles, Ben Wheeler, Alisa Boucsein, et al.
JAMA Network Open|August 27, 2025
Global Inequities in Diabetes Technology and Insulin Access and Glycemic OutcomesAlzbeta Santova, Martin de Bock, Stefanie Lanzinger, et al.
Diabetologia|October 23, 2023
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data InfrastructureNicholas Bowden, Rachael Dixon, Vivienne Anderson, et al.
Hormone Research in Paediatrics|December 19, 2024
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic TargetsMartin de Bock, Juliana Chizo Agwu, Matt Deabreu, et al.
JMIR Diabetes|May 28, 2026
Exploring User Experiences With the Lift App for Emotional Well-Being Among Youth With Type 1 Diabetes: Qualitative StudyKatie M Babbott, Kristin Harrison Ginsberg, Anna L Boggiss, et al.
BMC Endocrine Disorders|August 30, 2024
Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: a single-arm multi-phase intervention studyShekhar Sehgal, Martin De Bock, Benyamin Grosman, et al.
Pageof 9